University of Pittsburgh Health Sciences eLearning Environment Internet-based Studies in Education and Research
INTRODUCTION
ABIM MOC Activity ID
3/13/2018 - Medical Grand Rounds: Rheumatoid Arthritis, from the clinic back to the bench & Immune Relevance of Prevotella copri, a Gut Microbe, in Patient with Rheumatoid Arthritis
QUIZ
EVALUATION
CERTIFICATE
Credit Hours: CME 1.00
Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.
Upon completion of this activity, participants should be able to:
- Provide overview of major advances in treatment of rheumatoid arthritis.
- Review the strategies for prevention and early treatment for rheumatoid arthritis
- Describe the factors associated with poor prognosis, and challenges of treating rheumatoid arthritis
Presentation Topics
Title: Rheumatoid Arthritis, from the clinic back to the bench
Presenter: Larry Moreland, MD
Title:Immune Relevance of Prevotella copri, a Gut Microbe, in Patient with Rheumatoid Arthritis
Presenter: Allan C. Steere, MD
No relationships with industry relevant to the content of this educational activity have been disclosed.
Dr. Moreland receives research funding from NIH, Genentech, Pfizer, Mallinckrodt Pharmaceuticals, Roche, and Bristol Myers Squibb. Dr. Moreland is a consultant with Pfizer (DSMB) and Boehringer Ingelheim (DSMB).
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits. Each physician should only claim credit commensurate with the extent of their participation in the activity.
The University of Pittsburgh is an affirmative action, equal opportunity institution.